Cargando…
Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients
BACKGROUND: Echocardiographic evaluation of left ventricular (LV) structural and functional alterations in hypertension has some limitations, potentially overcome by using biomarkers. ST2, a prognostic biomarker for heart failure and myocardial infarction patients, was less studied in hypertension....
Autores principales: | Farcaş, Anca Daniela, Anton, Florin Petru, Goidescu, Cerasela Mihaela, Gavrilă, Iulia Laura, Vida-Simiti, Luminiţa Animarie, Stoia, Mirela Anca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439179/ https://www.ncbi.nlm.nih.gov/pubmed/28566800 http://dx.doi.org/10.1155/2017/2714095 |
Ejemplares similares
-
Better prognosis in overweight/obese coronary heart disease patients with high plasma levels of leptin
por: SIMITI, LUMINITA ANIMARIE VIDA, et al.
Publicado: (2016) -
Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients
por: Farcaş, Anca Daniela, et al.
Publicado: (2020) -
Biomarkers of Inflammation in Left Ventricular Diastolic Dysfunction
por: Mocan, Mihaela, et al.
Publicado: (2019) -
Hemodynamic monitoring using thoracic bioimpedance – an optimal solution for the treatment of hypertension
por: FARCAS, ANCA DANIELA, et al.
Publicado: (2018) -
The Apelin-APJ System in the Evolution of Heart Failure
por: GOIDESCU, CERASELA MIHAELA, et al.
Publicado: (2015)